• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国心力衰竭治疗的进展。

Progress in heart failure treatment in Germany.

机构信息

Internal Medicine III, University Hospital of Schleswig Holstein, Campus Kiel, Rosalind-Franklin-Str.12, 24105, Kiel, Germany.

出版信息

Clin Res Cardiol. 2018 Aug;107(Suppl 2):105-113. doi: 10.1007/s00392-018-1317-0. Epub 2018 Jul 2.

DOI:10.1007/s00392-018-1317-0
PMID:29968196
Abstract

Acute and chronic heart failure is still a major cause of morbidity and mortality in Europe. Nevertheless, significant progress has been made in diagnosis and treatment of heart failure as well as in unraveling its molecular causes. Here, we focus on some relevant contributions to these achievements by German cardiovascular clinicians and scientists.

摘要

在欧洲,急性和慢性心力衰竭仍然是发病率和死亡率的主要原因。尽管如此,心力衰竭的诊断和治疗以及对其分子病因的研究都取得了重大进展。在这里,我们重点介绍德国心血管临床医生和科学家在这些成就中所做的一些相关贡献。

相似文献

1
Progress in heart failure treatment in Germany.德国心力衰竭治疗的进展。
Clin Res Cardiol. 2018 Aug;107(Suppl 2):105-113. doi: 10.1007/s00392-018-1317-0. Epub 2018 Jul 2.
2
[The German National Disease Management Guideline "Chronic Heart Failure"].[德国国家疾病管理指南“慢性心力衰竭”]
Dtsch Med Wochenschr. 2012 Feb;137(5):219-27. doi: 10.1055/s-0031-1292894. Epub 2012 Jan 25.
3
[Differences between German and Turkish-speaking participants in a chronic heart failure management program].[慢性心力衰竭管理项目中德语和土耳其语使用者参与者之间的差异]
Herz. 2017 Feb;42(1):84-90. doi: 10.1007/s00059-016-4440-6. Epub 2016 Jun 22.
4
Treatment of chronic heart failure in Germany: a retrospective database study.德国慢性心力衰竭的治疗:一项回顾性数据库研究。
Clin Res Cardiol. 2017 Nov;106(11):923-932. doi: 10.1007/s00392-017-1138-6. Epub 2017 Jul 26.
5
Current Management of Heart Failure: When to Refer to Heart Failure Specialist and When Hospice is the Best Option.心力衰竭的当前管理:何时转介心力衰竭专科医生以及何时临终关怀是最佳选择。
Med Clin North Am. 2015 Jul;99(4):863-76. doi: 10.1016/j.mcna.2015.02.012. Epub 2015 Apr 18.
6
Performance Improvement in Healthcare: Is Personalized Site Feedback Enough?医疗保健中的绩效改进:个性化的现场反馈是否足够?
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):335-7. doi: 10.1161/CIRCOUTCOMES.115.002039. Epub 2015 Jul 14.
7
Management considerations in the care of elderly heart failure patients in long-term care facilities.长期护理机构中老年心力衰竭患者护理中的管理考量
Future Cardiol. 2014 Jul;10(4):563-77. doi: 10.2217/fca.14.35.
8
[Treatment guidelines--chronic heart failure. Recommendations for therapy of chronic heart failure of the Medical Commission of the German Medical Branch].[治疗指南——慢性心力衰竭。德国医学协会医学委员会关于慢性心力衰竭治疗的建议]
Z Arztl Fortbild Qualitatssich. 1999 Jan;93(1):45-8.
9
[Guideline compliance in the treatment of patients with chronic heart failure through family doctor-centred health care: results of an evaluation study].[通过以家庭医生为中心的医疗保健对慢性心力衰竭患者进行治疗的指南依从性:一项评估研究的结果]
Z Evid Fortbild Qual Gesundhwes. 2013;107(6):394-402. doi: 10.1016/j.zefq.2013.08.010. Epub 2013 Sep 4.
10
Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study.提高欧洲对心力衰竭的认识和认知并改善护理——SHAPE研究的基本原理与设计
Cardiovasc Drugs Ther. 2004 Mar;18(2):153-9. doi: 10.1023/B:CARD.0000029033.83282.d0.

引用本文的文献

1
Heart failure and dementia: a comparative analysis with different types of cancer.心力衰竭与痴呆症:与不同类型癌症的比较分析
Eur Heart J Open. 2021 Jul 24;1(1):oeab003. doi: 10.1093/ehjopen/oeab003. eCollection 2021 Aug.
2
Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.微生物组医学:心血管疾病的发生发展与防治中的微生物群。
Endocr Metab Immune Disord Drug Targets. 2022;22(14):1344-1356. doi: 10.2174/1871530322666220624161712.
3
The spectrum of comorbidities at the initial diagnosis of heart failure a case control study.

本文引用的文献

1
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.随机对照试验评估心脏收缩力调节的安全性和疗效。
JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10.
2
Mitral valve interventions in heart failure.心力衰竭的二尖瓣介入治疗。
ESC Heart Fail. 2018 Aug;5(4):552-561. doi: 10.1002/ehf2.12287. Epub 2018 Apr 19.
3
Implantable devices for heart failure monitoring and therapy.心力衰竭监测和治疗的植入式设备。
心力衰竭初始诊断时合并症的谱:一项病例对照研究。
Sci Rep. 2022 Feb 17;12(1):2670. doi: 10.1038/s41598-022-06618-5.
4
[Update on diagnostics and treatment of heart failure].[心力衰竭的诊断与治疗进展]
Herz. 2022 Aug;47(4):340-353. doi: 10.1007/s00059-021-05062-x. Epub 2021 Aug 31.
5
Growth differentiation factor 11 is involved in isoproterenol‑induced heart failure.生长分化因子 11 参与异丙肾上腺素诱导的心力衰竭。
Mol Med Rep. 2019 May;19(5):4109-4118. doi: 10.3892/mmr.2019.10077. Epub 2019 Mar 22.
6
Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count.一名外周血嗜酸性粒细胞计数正常的患者出现与莫达非尼相关的严重嗜酸性粒细胞性心肌炎。
Clin Res Cardiol. 2019 Aug;108(8):963-966. doi: 10.1007/s00392-019-01434-w. Epub 2019 Feb 12.
7
Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.高危 ICD 人群中室性心动过速/心室颤动复发和恰当 ICD 治疗的预后影响。
Clin Res Cardiol. 2019 Aug;108(8):878-891. doi: 10.1007/s00392-019-01416-y. Epub 2019 Feb 12.
Heart Fail Rev. 2018 Nov;23(6):935-944. doi: 10.1007/s10741-018-9687-y.
4
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.通过对两个独立队列的分析确定的心力衰竭肠道微生物群特征
J Am Coll Cardiol. 2018 Mar 13;71(10):1184-1186. doi: 10.1016/j.jacc.2017.12.057.
5
Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients.宏基因组学和代谢组学分析揭示慢性心力衰竭患者肠道微生物群落失调。
Sci Rep. 2018 Jan 12;8(1):635. doi: 10.1038/s41598-017-18756-2.
6
Gut microbiota in cardiovascular disease and heart failure.心血管疾病和心力衰竭中的肠道微生物群。
Clin Sci (Lond). 2018 Jan 11;132(1):85-91. doi: 10.1042/CS20171090. Print 2018 Jan 16.
7
Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG).射血分数保留型心力衰竭:当前的管理与未来策略:德国心脏病学会(DKG)心力衰竭工作组核心成员的专家意见。
Clin Res Cardiol. 2018 Jan;107(1):1-19. doi: 10.1007/s00392-017-1170-6. Epub 2017 Oct 10.
8
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure.全基因组关联研究鉴定心力衰竭的心脏基因图谱和一类新的生物标志物。
Circulation. 2017 Oct 17;136(16):1528-1544. doi: 10.1161/CIRCULATIONAHA.117.027355. Epub 2017 Aug 24.
9
Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry.经导管二尖瓣介入治疗(TRAMI)注册研究:重度左心室射血分数降低患者应用 MitraClip™ 治疗的安全性和有效性。
Eur J Heart Fail. 2018 Mar;20(3):598-608. doi: 10.1002/ejhf.910. Epub 2017 Aug 18.
10
Heart failure is associated with depletion of core intestinal microbiota.心力衰竭与肠道核心微生物群的耗竭有关。
ESC Heart Fail. 2017 Aug;4(3):282-290. doi: 10.1002/ehf2.12155. Epub 2017 Apr 21.